What SINTX Technologies does

SINTX Technologies, Inc. (NASDAQ: SINT) is a Salt Lake City-based advanced ceramics company founded in 1996 that manufactures silicon nitride (Si3N4) materials and medical devices. Its core platform is proprietary silicon nitride, which combines inherent antibacterial and antiviral properties with osteogenic/osseointegrative performance — features the company positions as differentiated versus PEEK and titanium implants in spine and orthopedic use cases. The company holds FDA 510(k) clearance for spinal implants (commercial use since 2008, 50,000+ implants placed) and for the SINAPTIC Foot & Ankle Osteotomy Wedge System (cleared October 2025), and is expanding into composite 3D printing via an Evonik-supplied silicon nitride-PEEK compound. Its product portfolio spans the Valeo spinal interbody family, SINAPTIC foot and ankle systems, SiNERGY composites, OsseoSculpt biologics, FleX-SN antipathogenic powders, and BoroShock boron carbide industrial ceramics. The company also performs contract advanced-ceramic component manufacturing for OEM customers in aerospace, defense, and industrial markets.

SINTX generates revenue through direct sales of FDA-cleared medical devices to hospitals and orthopedic surgeons, OEM supply agreements (Evonik for SiN/PEEK compound, O2TODAY for antipathogenic face-mask materials), licensing of silicon nitride and antipathogenic fabric IP, distributor relationships for international reach, and contract manufacturing of advanced ceramic components. Pricing for medical devices is not publicly disclosed and is set via GPO contracts and hospital/surgeon negotiations; industrial contract-manufacturing pricing is volume- and complexity-based. The go-to-market combines enterprise field sales to surgical channels, OEM partnerships for material and component supply, and distributor programs for regional coverage in the U.S., Brazil, Europe, and Taiwan. Revenue remains very small (Q1 2026 of $0.38M, Q4 2025 ~$0.30M) as the company transitions from a single-product spinal implant business toward a diversified biomaterials and contract-manufacturing platform, with the SINAPTIC Foot & Ankle launch, OsseoSculpt biologic, and Evonik SiN/PEEK supply agreement representing the principal near-term growth vectors.

Name

SINTX Technologies

Legal name

SINTX Technologies, Inc.

Website

https://sintx.com

Company type

Public

Founded year

1996

Operating status

Operating

Headcount range

11–50 employees

Short description

SINTX Technologies (NASDAQ: SINT) is a Salt Lake City advanced ceramics company that manufactures silicon nitride medical devices — spinal implants, the SINAPTIC foot and ankle system, antipathogenic powders, and OEM composite materials — and sells to hospitals, surgeons, and industrial customers.

Ownership category

akta.pro rank

Product category

Orthopedic Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ)

akta.pro secondary industry

Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)

Keywords

• Silicon nitride implants
• Spinal fusion devices
• Foot ankle reconstruction
• Antipathogenic materials
• Advanced ceramic manufacturing

Headquarters

HQ city

Salt Lake City

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Medical Device Sales: Sale of FDA-cleared silicon nitride medical devices including spinal implants (Valeo line), foot and ankle reconstruction systems (SINAPTIC), and dental implants. Revenue generated from direct hospital and surgeon sales as well as through distribution partnerships.
2. Contract Manufacturing: Advanced ceramic component manufacturing services for OEM customers. The company secured purchase orders exceeding $3.2 million from multiple contract manufacturing customers for advanced ceramic component production in 2026.
3. Technology Licensing: Licensing of silicon nitride technology, antipathogenic fabric patents, and composite materials to medical device manufacturers. Company pursued strategic options with Ascendiant Capital Markets as exclusive advisor in 2024.
4. Materials Sales: Sale of silicon nitride powders (FleX-SN-AP for antipathogenic applications) and industrial silicon nitride materials for aerospace, automotive, and industrial manufacturing applications.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

SINTX Technologies manufactures and sells silicon nitride (Si3N4) advanced ceramic medical devices, including FDA-cleared spinal interbody fusion implants and foot and ankle reconstruction systems, as well as antipathogenic silicon nitride powders (FleX SN-AP) for medical textiles and infection-prevention products. The company also provides silicon nitride–PEEK (SiNERGY) composites for 3D-printed patient-specific implants and contract-manufactured advanced ceramic components for aerospace, defense, and industrial customers.

Differentiator

Problem solved

Functional benefit

Brands

• SiNAPTIC Surgical: Brand for foot and ankle reconstruction medical devices, acquired July 1, 2025
• OsseoSculpt
• SiNERGY
• Valeo
• FleX-SN
• BoroShock

Products and services

• SINAPTIC Foot & Ankle Osteotomy Wedge System FDA-cleared foot and ankle reconstruction implant system made from silicon nitride biomaterial, designed for orthopedic surgeons performing foot osteotomy and fusion procedures.
• Valeo Spinal Fusion Implants Silicon nitride interbody fusion devices for spinal surgery, including Valeo TL and Valeo II product lines, used by hospitals and orthopedic spine surgeons.
• FleX-SN Medical-Grade Silicon Nitride Materials Medical-grade silicon nitride powder and composite materials used as base biomaterial for implants and as raw input for medical device OEMs.
• FleX SN-AP Antipathogenic Powder Antipathogenic silicon nitride powder designed to be embedded in fabrics or used as a coating to impart antiviral and antibacterial properties to medical textiles and infection-prevention products.
• SiNERGY SiN/PEEK Composite Proprietary silicon nitride–PEEK composite biomaterial for orthopedic and spinal applications, enabling 3D-printed patient-specific implants with antipathogenic and osteogenic properties.
• OsseoSculpt Biologic Product Advanced biologic adjunct product used together with the SINAPTIC Foot & Ankle Osteotomy Wedge System to support bone healing in foot and ankle reconstruction procedures.
• Composite 3D Printing / Contract Manufacturing Services Custom advanced ceramic component manufacturing service, including ceramic 3D printing of silicon nitride and boron carbide parts, for medical, aerospace, defense, and industrial OEM customers.
• Industrial Ceramic Components (Silicon Nitride and Boron Carbide) Custom silicon nitride and boron carbide ceramic components (such as ball bearings, radomes, RF windows, engine components, and seals) sold directly to aerospace, defense, and industrial OEM customers.

Quantifiable outcome

• Over 50,000 silicon nitride spinal implants successfully placed since 2008
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Evonik CorporationcoreStrategic or Co-development Partner · 2 December 2025SINTX signed a supply agreement with Evonik to manufacture proprietary silicon nitride-PEEK (SiN/PEEK) compound for AI-assisted additive manufacturing of patient-specific implants. Evonik produces the compound to SINTX's specifications at industrial scale, enabling immediate manufacturing of 3D-printed patient-specific implants. The partnership combines Evonik's PEEK polymer manufacturing expertise with SINTX's silicon nitride biomaterial capabilities.
• SiNAPTIC Surgical, LLCcoreOEM/ Whitelabel/ Licensing Partner · 1 September 2025SINTX acquired SiNAPTIC Surgical, LLC in September 2025 for an undisclosed sum to enhance ceramic additive manufacturing capabilities and accelerate commercialization of silicon nitride-based orthopedic and spinal implant technologies. The acquisition provided the SINAPTIC brand and associated product rights.
• O2TODAYminorChannel Partner/ Reseller/ Distributor · 14 July 2021Partnership to incorporate SINTX's FleX SN-AP silicon nitride antipathogenic powder into fabric fibers for non-woven face mask materials. O2TODAY manufactures and distributes face masks and other textile products using the treated materials.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Globus Medical (formerly NuVasive): One of the largest pure-play spinal fusion and orthopedic implant companies, with a deep portfolio of interbody devices and biologics. Directly competes with SINTX's Valeo spinal implant line for hospital and surgeon adoption in spine fusion procedures.
• SeaSpine Holdings: Spine-focused medical device company developing interbody fusion devices, fixation systems, and biologics. Directly comparable to SINTX in targeting spinal fusion surgeons with a differentiated material/biological value proposition.
• Orthofix Medical: Spine and orthopedic reconstruction company with biologics, fixation, and extremity reconstruction products. Comparable as a competitor in spinal fusion and emerging extremity reconstruction, the same segments SINTX targets with silicon nitride.
• Alphatec Spine: Independent spine company with a portfolio of interbody, fixation, and biologics products. Competes in the same spinal fusion hospital channel as SINTX's Valeo implants and shares a similar focus on surgeon-driven adoption.
• SI-BONE: Specialty orthopedic device company using differentiated implant material (titanium-coated silicone for sacroiliac joint fusion). Comparable as a small-cap, single-category orthopedic pure-play with novel-material implants sold through spine/extremity surgeons.

Broad incumbents

• Stryker: Diversified medical device leader with a large spine and orthopedic implant franchise and biologics portfolio. Competes broadly with SINTX in hospital and surgeon channels and sets the benchmark for what scale-driven commercial execution looks like.
• Zimmer Biomet: Global leader in orthopedic reconstruction (hips, knees, extremities) with biomaterials and biologics offerings. Provides the incumbent benchmark in joint replacement implants, the broader category SINTX targets with its silicon nitride materials.
• Medtronic (Spinal & Biologics): Largest spinal implant franchise globally, with INFUSE bone graft and interbody devices. Represents the dominant incumbent that SINTX's Valeo silicon nitride interbody line must compete against for surgeon adoption and hospital contracts.
• CeramTec: Large advanced ceramics manufacturer with a medical division producing ceramic hip and dental implants (e.g., BIOLOX). Comparable as an established technical ceramics player in medical devices that competes with SINTX in ceramic biomaterials and contract manufacturing.

Emerging players

• Victrex (Invibio): PEEK polymer specialist with an Invibio biomaterials division supplying medical-grade PEEK for spinal and orthopedic implants. Directly comparable as SINTX's SiN/PEEK co-development partner with Evonik and a competing biomaterials platform in the same implant applications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCrIPzvaIfiXbzzwhjF0RePA
• LinkedInlinkedin.com/company/sintx
• Xx.com/AmedicaCorp
• Facebookfacebook.com/AmedicaCorporation

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Subsidiaries1 record

Funding overview

Funding rounds19 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SINTX Technologies